# Pioglitazone

NDC: 33342-055
Generic name: Pioglitazone
Labeler / Manufacturer: Macleods Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20130214

FDA application: ANDA202467

## Active ingredients

- PIOGLITAZONE HYDROCHLORIDE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"33342-055"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=33342-055
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=482cef76-0623-4b4f-a0ea-f008c97b2281